Brief: Adial Pharmaceuticals Provides Update On Regulatory Strategy For AD04

Azora Therapeutics

06/03/2023 23:40

March 6 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS PROVIDES UPDATE ON REGULATORY
STRATEGY FOR
AD04 FOR TREATMENT OF ALCOHOL USE DISORDER
    * ADIAL PHARMACEUTICALS INC - TO PURSUE PATH TOWARD U.S. AND
EUROPEAN APPROVALS; TYPE C MEETING WITH FDA CONFIRMED FOR Q2
2023
    * ADIAL PHARMACEUTICALS INC - TYPE C MEETING WITH FDA
CONFIRMED
FOR Q2 2023 TO DISCUSS CLINICAL PROGRAM IN U.S.
    * ADIAL PHARMACEUTICALS INC - PLANS IN PLACE TO MEET WITH
MULTIPLE
EUROPEAN REGULATORY AUTHORITIES

Source text for Eikon:  ID:nGNX1tGQGK 
Further company coverage:  ADIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))